These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 15630843)

  • 41. The effects of PSA kinetics on the outcome of hypofractionated salvage radiotherapy for biochemical recurrence of prostate cancer after prostatectomy.
    Ishikawa H; Higuchi K; Kaminuma T; Takezawa Y; Saito Y; Etsunaga T; Maruo K; Kawamura H; Kubo N; Nakano T; Kobayashi M
    J Radiat Res; 2020 Nov; 61(6):908-919. PubMed ID: 32888035
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prostate-specific antigen velocity accurately predicts response to salvage radiotherapy in men with biochemical relapse after radical prostatectomy.
    Patel R; Lepor H; Thiel RP; Taneja SS
    Urology; 2005 May; 65(5):942-6. PubMed ID: 15882728
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A phase 2 multimodality trial of docetaxel/prednisone with sunitinib followed by salvage radiation therapy in men with PSA recurrent prostate cancer after radical prostatectomy.
    Armstrong AJ; Halabi S; Healy P; Lee WR; Koontz BF; Moul JW; Mundy K; Creel P; Wood S; Davis K; Carducci MA; Stein M; Hobbs C; Reimer B; Nguyen M; Anand M; Bratt L; Kim S; Tran PT; George DJ;
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):100-6. PubMed ID: 26754260
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Salvage radiation for a rising PSA following radical prostatectomy.
    Maier J; Forman J; Tekyi-Mensah S; Bolton S; Patel R; Pontes JE
    Urol Oncol; 2004; 22(1):50-6. PubMed ID: 14969805
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Treatment results of salvage radiotherapy for biochemical recurrence after radical prostatectomy].
    Hatano K; Kinouchi T; Kinoshita T; Kobayashi M; Inoue H; Takada T; Hara T
    Nihon Hinyokika Gakkai Zasshi; 2009 Nov; 100(7):671-8. PubMed ID: 19999131
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Salvage intensity-modulated radiotherapy for rising PSA after radical prostatectomy.
    De Meerleer G; Fonteyne V; Meersschout S; Van den Broecke C; Villeirs G; Lumen N; Ost P; Vandecasteele K; De Neve W
    Radiother Oncol; 2008 Nov; 89(2):205-13. PubMed ID: 18771809
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of factors predicting response to adjuvant radiation therapy in patients with positive margins after radical prostatectomy.
    Kamat AM; Babaian K; Cheung MR; Naya Y; Huang SH; Kuban D; Babaian RJ
    J Urol; 2003 Nov; 170(5):1860-3. PubMed ID: 14532793
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Radiotherapy for men with isolated increase in serum prostate specific antigen after radical prostatectomy.
    Macdonald OK; Schild SE; Vora SA; Andrews PE; Ferrigni RG; Novicki DE; Swanson SK; Wong WW
    J Urol; 2003 Nov; 170(5):1833-7. PubMed ID: 14532786
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial (NCT00541047).
    Parker CC; Petersen PM; Cook AD; Clarke NW; Catton C; Cross WR; Kynaston H; Parulekar WR; Persad RA; Saad F; Bower L; Durkan GC; Logue J; Maniatis C; Noor D; Payne H; Anderson J; Bahl AK; Bashir F; Bottomley DM; Brasso K; Capaldi L; Chung C; Cooke PW; Donohue JF; Eddy B; Heath CM; Henderson A; Henry A; Jaganathan R; Jakobsen H; James ND; Joseph J; Lees K; Lester J; Lindberg H; Makar A; Morris SL; Oommen N; Ostler P; Owen L; Patel P; Pope A; Popert R; Raman R; Ramani V; Røder A; Sayers I; Simms M; Srinivasan V; Sundaram S; Tarver KL; Tran A; Wells P; Wilson J; Zarkar AM; Parmar MKB; Sydes MR;
    Ann Oncol; 2024 Jul; 35(7):656-666. PubMed ID: 38583574
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identifying appropriate patients for early salvage radiotherapy after prostatectomy.
    Karlin JD; Koontz BF; Freedland SJ; Moul JW; Grob BM; Wan W; Hagan MP; Anscher MS; Moghanaki D
    J Urol; 2013 Oct; 190(4):1410-5. PubMed ID: 23648223
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Salvage radical prostatectomy: outcome measured by serum prostate specific antigen levels.
    Rogers E; Ohori M; Kassabian VS; Wheeler TM; Scardino PT
    J Urol; 1995 Jan; 153(1):104-10. PubMed ID: 7526002
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prostate-specific antigen doubling time subsequent to radical prostatectomy is a predictor of outcome following salvage external beam radiation therapy: a single-centre experience.
    Servoll E; Sæter T; Vlatkovic L; Nesland JM; Waaler G; Axcrona K
    Scand J Urol; 2015 Jun; 49(3):218-23. PubMed ID: 25428750
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adjuvant versus early salvage radiotherapy: outcome of patients with prostate cancer treated with postoperative radiotherapy after radical prostatectomy.
    Vogel MME; Kessel KA; Schiller K; Devecka M; Gschwend JE; Weichert W; Wilkens JJ; Combs SE
    Radiat Oncol; 2019 Nov; 14(1):198. PubMed ID: 31711524
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outcome of salvage radiotherapy for biochemical failure after radical prostatectomy with or without hormonal therapy.
    Cheung R; Kamat AM; de Crevoisier R; Allen PK; Lee AK; Tucker SL; Pisters L; Babaian RJ; Kuban D
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):134-40. PubMed ID: 16111581
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The impact of a negative (111)indium-capromab pendetide scan before salvage radiotherapy.
    Proaño JM; Sodee DB; Resnick MI; Einstein DB
    J Urol; 2006 May; 175(5):1668-72. PubMed ID: 16600726
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic factors after salvage radiotherapy alone in patients with biochemical recurrence after radical prostatectomy.
    Song W; Jeon HG; Sung HH; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
    Int J Urol; 2016 Jan; 23(1):56-61. PubMed ID: 26502086
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Salvage radiotherapy in prostate cancer patients with biochemical relapse after radical prostatectomy : Prolongation of prostate-specific antigen doubling time in patients with subsequent biochemical progression.
    Lohm G; Neumann K; Budach V; Wiegel T; Hoecht S; Gollrad J
    Strahlenther Onkol; 2018 Apr; 194(4):325-332. PubMed ID: 29255924
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early salvage radiotherapy for patients with PSA relapse after radical prostatectomy.
    Tomita N; Kodaira T; Furutani K; Tachibana H; Nakahara R; Mizoguchi N; Hayashi N
    J Cancer Res Clin Oncol; 2009 Nov; 135(11):1561-7. PubMed ID: 19479278
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Retrospective analysis of predicting biochemical recurrence after initial radical prostatectomy].
    Namura K; Onuki T; Kouno M; Ishigaki H; Kato Y; Tajiri T; Sawada T; Fujikawa A; Ota J; Moriyama M; Hayashi H; Yoshida S; Harada M
    Hinyokika Kiyo; 2013 Aug; 59(8):485-9. PubMed ID: 23995523
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Larger maximum tumor diameter at radical prostatectomy is associated with increased biochemical failure, metastasis, and death from prostate cancer after salvage radiation for prostate cancer.
    Johnson SB; Hamstra DA; Jackson WC; Zhou J; Foster B; Foster C; Song Y; Li D; Palapattu GS; Kunju L; Mehra R; Sandler H; Feng FY
    Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):275-81. PubMed ID: 23886418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.